Treatment with Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) with Acute Myeloid Leukemia: A Single Institution Experience

OBJECTIVES: Low-dose cytarabine (LD-AraC) is still regarded as the standard of care in elderly patients with acute myeloid leukemia (AML) ‘unfit’ for intensive chemotherapy. In this study, we reported our experience with LD-AraC in patients ≥ 70 years old and compared the results to those of intensi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mediterr J Hematol Infect Dis
Main Authors: Heiblig, Maël, Elhamri, Mohamed, Tigaud, Isabelle, Plesa, Adriana, Barraco, Fiorenza, Labussière, Hélène, Ducastelle, Sophie, Michallet, Mauricette, Nicolini, Franck, Plesa, Claudiu, Wattel, Eric, Salles, Gilles, Thomas, Xavier
Format: Artigo
Jezik:Inglês
Izdano: Università Cattolica del Sacro Cuore 2016
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4696467/
https://ncbi.nlm.nih.gov/pubmed/26740870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2016.009
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki